MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: dystonia"

  • 2023 International Congress

    Dystonia in the Middle East – The Cleveland Clinic Abu Dhabi Experience

    S. Mansoor, K. Waqar, M. Thomas, S. Mittal (Abu Dhabi, United Arab Emirates)

    Objective: This study aimed to evaluate the clinical spectrum of patients with dystonia seen at Cleveland Clinic Abu Dhabi Hospital (CCAD), a tertiary care center…
  • 2023 International Congress

    Botulinum toxin injections for lingual protrusion dystonia: a review of the muscle target and dosage

    A. Duarte, H. Ghizoni Teive (Curitiba, Brazil)

    Objective: The aim of our study was to perform a literature review about the botulinum toxin types, their dosage and muscle target in the treatment…
  • 2023 International Congress

    Perception of the subjective visual vertical in subjects with cervical dystonia

    I. Reuter (Gießen, Germany)

    Objective: The Aim of the study was to assess:1.) if the perception of the visual vertical (VV) is impaired in subjects with cervical dystonia (CDsub),…
  • 2023 International Congress

    Quantifying the impact of sensory tricks on the overall severity of cervical dystonia

    A. Mahajan, D. Gonzalez, G. Stebbins, C. Comella (Chicago, USA)

    Objective: To quantify the impact of sensory trick on botulinum toxin dose and treatment outcomes in cervical dystonia (CD) Background: Sensory tricks are voluntary maneuvers…
  • 2023 International Congress

    Early-onset levodopa-responsive Parkinsonism associated with dysarthria, pyramidalism, and dystonia: a rare condition that can benefit from a combined treatment approach.

    L. Gallo, M. Avenali, P. Mitrotti, C. Tassorelli, R. Zangaglia, F. Valentino, S. Gana, EM. Valente, C. Pacchetti, G. Cosentino (Pavia, Italy)

    Objective: To describe a rare case of early-onset parkinsonism (EOP) successfully treated with a combined therapeutic approach. Background: EOP is a rare condition manifesting with…
  • 2022 International Congress

    Botulinum Toxin Therapy for Medication and DBS Refractory Foot Dystonia of Parkinsonism

    E. Zinoviev, M. Ganapathy, M. Siddiqui (Winston-Salem, USA)

    Objective: To determine efficacy and safety of BTX therapy in patients with medically refractory foot dystonia secondary to Parkinson’s disease (PD) or atypical Parkinsonism (AP)…
  • 2022 International Congress

    Application of Goal Attainment Scale as a patient-centered assessment for cervical dystonia

    P. Wongwan, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To explore the goal attainment scale (GAS) by interviewing the three most disturbing problems and changes after Botulinum toxin A injection in cervical dystonia…
  • 2022 International Congress

    Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia

    A. Silbergleit, L. Schultz, K. Isabell, J. Turnbull, E. Boettcher, R. Konnai, C. Sidiropoulos, N. Patel (West Bloomfield, USA)

    Objective: 1.To determine if Botulinum toxin (BoNT) injection improves oropharyngeal swallowing in individuals with cervical dystonia (CD) as determined by objective data from videofluorographic swallowing studies…
  • 2022 International Congress

    PHENOTYPIC DESCRIPTION OF TWO UNREPORTED FAMILIES WITH ANO3 DYSTONIA

    A. Trinchillo, G. de Joanna, M. Esposito (Naples, Italy)

    Objective: This is the phenotypic description of two families affected by hereditary dystonia associated to gene ANO3 mutation (DYT24), one with a heterozygous verisimilarly pathogenic…
  • 2022 International Congress

    Characterization of routine botulinum toxin (BoNT) therapy and patient population in cervical dystonia

    B. Waeschle, H. Stark, P. Albrecht (Düsseldorf, Germany)

    Objective: We conducted a survey to characterize real-world treatment of CD patients with focus on treatment duration, clinical parameters and awareness of clinical resistance as…
  • « Previous Page
  • 1
  • …
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 21
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley